The RNA‐binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer. Most patients present with advanced disease at diagnosis, which only permits palliative chemotherapeutic treatments. RNA dysregulation is a hallmark of most human cancers, including PDAC. To test the impact of RNA processing dysr...

Descripción completa

Detalles Bibliográficos
Autores principales: Panzeri, Valentina, Manni, Isabella, Capone, Alessia, Naro, Chiara, Sacconi, Andrea, Di Agostino, Silvia, de Latouliere, Luisa, Montori, Andrea, Pilozzi, Emanuela, Piaggio, Giulia, Capurso, Gabriele, Sette, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858117/
https://www.ncbi.nlm.nih.gov/pubmed/33159833
http://dx.doi.org/10.1002/1878-0261.12847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858117/
https://www.ncbi.nlm.nih.gov/pubmed/33159833
http://dx.doi.org/10.1002/1878-0261.12847

Ejemplares similares